Skip to main content
SpringerLink
Log in

Erste wirksame Therapie eines schwierigen Karzinoms

Dabrafenib plus Trametinib beim anaplastischen Schilddrüsenkarzinom mit BRAF-Mutation

  • journal club
  • Published:
InFo Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1

Literatur

  1. Tiedje V et al. Endocr Relat Cancer. 2018 Jan 2. pii: ERC-17-0435.

  2. Flaherty KT et al. New Engl J Med 2012;367(18):1694–703.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Takano T. Endocr J 2017;64(3):237–244.

    Article  PubMed  Google Scholar 

  4. Ahn HS, Welch HG. N Engl J Med. 2015;373(24):2389–90.

    Article  CAS  PubMed  Google Scholar 

  5. Wada N et al. Ann Surg. 2003;237(3):399–407.

    PubMed  PubMed Central  Google Scholar 

  6. Simpson KW, Albores-Saavedra J. Ann Diagn Pathol. 2007;11(2):97–102.

    Article  PubMed  Google Scholar 

  7. Tuttle RM et al. JAMA Otolaryngol Head Neck Surg. 2017;143(10):1015–20.

    Article  PubMed  Google Scholar 

  8. Shen X et al. J Clin Oncol. 2017;JCO2017745497 (Epub ahead of print).

  9. Cabanillas ME et al. Horm Cancer 2015;6(1):21–36.

    Article  CAS  PubMed  Google Scholar 

  10. Shah MH. ASCO 2017:Abstr 6022.

  11. McFadden DG et al. Proc Natl Acad Sci USA. 2014;111(16):E1600–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Liu L et al. Cell Physiol Biochem 2017;43(3):905–14.

    Article  CAS  PubMed  Google Scholar 

  13. Oishi N et al. Mod Pathol 2017;30(11):1527–37.

    Article  CAS  PubMed  Google Scholar 

  14. Iyer PC et al. Thyroid 2018;28(1):79–87.

    Article  CAS  PubMed  Google Scholar 

Originalie

  • Subbiah V et al. Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer. J Clin Oncol. 2018;36(1):7–13.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Fürth, Deutschland

    Michael Fink

Authors
  1. Michael Fink
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Fink.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fink, M. Dabrafenib plus Trametinib beim anaplastischen Schilddrüsenkarzinom mit BRAF-Mutation. Info Onkol. 21, 10–12 (2018). https://doi.org/10.1007/s15004-018-5948-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-018-5948-0

Schlüsselwörter

Search

Navigation